TipRanks
Halozyme Therapeutics (GB:0J2O)
LSE:0J2O
UK Market
0J2O
Halozyme
RESEARCH TOOLSreports

Halozyme (0J2O) Ratios

1 Followers

Halozyme Ratios

GB:0J2O's free cash flow for Q2 2026 was $0.84. For the 2026 fiscal year, GB:0J2O's free cash flow was decreased by $ and operating cash flow was $0.60. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.71 4.66 7.80 6.64 5.65
Quick Ratio
 2.31 3.66 6.78 5.50 4.88
Cash Ratio
 0.47 0.76 0.83 1.05 1.79
Solvency Ratio
 0.22 0.16 0.31 0.22 0.15
Operating Cash Flow Ratio
 2.38 3.68 3.44 3.45 1.84
Short-Term Operating Cash Flow Coverage
 3.92 0.00 0.00 0.00 18.01
Net Current Asset Value
$ -1.50B$ -1.65B$ -614.32M$ -903.04M$ -932.70M
Leverage Ratios
Debt-to-Assets Ratio
 0.83 0.85 0.73 0.86 0.82
Debt-to-Equity Ratio
 14.95 43.89 4.14 17.89 8.87
Debt-to-Capital Ratio
 0.94 0.98 0.81 0.95 0.90
Long-Term Debt-to-Capital Ratio
 0.93 0.98 0.81 0.95 0.90
Financial Leverage Ratio
 17.96 51.73 5.67 20.68 10.85
Debt Service Coverage Ratio
 2.39 23.34 30.04 20.53 8.87
Interest Coverage Ratio
 45.84 44.28 30.48 17.99 15.79
Debt to Market Cap
 0.16 0.27 0.25 0.31 0.19
Interest Debt Per Share
 18.48 18.03 12.02 11.51 11.13
Net Debt to EBITDA
 2.76 3.51 2.12 3.06 4.03
Profitability Margins
Gross Profit Margin
82.42%83.62%84.30%76.80%78.90%
EBIT Margin
36.28%34.73%56.65%44.27%40.28%
EBITDA Margin
43.18%41.03%64.66%54.50%47.80%
Operating Profit Margin
55.95%57.47%54.32%40.71%40.53%
Pretax Profit Margin
35.06%33.43%54.87%42.01%37.71%
Net Profit Margin
24.86%22.69%43.74%33.96%30.62%
Continuous Operations Profit Margin
24.86%22.69%43.74%33.96%30.62%
Net Income Per EBT
70.90%67.87%79.71%80.84%81.20%
EBT Per EBIT
62.67%58.17%101.03%103.19%93.04%
Return on Assets (ROA)
16.05%12.55%21.52%16.25%10.98%
Return on Equity (ROE)
180.63%649.18%122.06%336.00%119.04%
Return on Capital Employed (ROCE)
41.68%34.18%28.66%20.83%15.64%
Return on Invested Capital (ROIC)
27.03%23.20%22.84%16.84%12.60%
Return on Tangible Assets
38.54%32.89%35.67%33.38%22.82%
Earnings Yield
3.19%3.93%7.32%5.78%2.60%
Efficiency Ratios
Receivables Turnover
 3.65 3.16 3.29 3.54 2.86
Payables Turnover
 12.39 10.95 15.55 16.28 7.87
Inventory Turnover
 2.13 1.30 1.12 1.51 1.39
Fixed Asset Turnover
 19.74 17.00 13.53 11.06 8.74
Asset Turnover
 0.65 0.55 0.49 0.48 0.36
Working Capital Turnover Ratio
 2.71 1.75 1.29 1.34 0.93
Cash Conversion Cycle
 241.71 363.54 412.22 322.79 343.75
Days of Sales Outstanding
 100.00 115.33 110.89 103.09 127.77
Days of Inventory Outstanding
 171.17 281.56 324.80 242.12 262.34
Days of Payables Outstanding
 29.47 33.34 23.47 22.42 46.36
Operating Cycle
 271.17 396.88 435.69 345.21 390.11
Cash Flow Ratios
Operating Cash Flow Per Share
 6.98 5.44 3.78 2.95 1.75
Free Cash Flow Per Share
 6.87 5.38 3.69 2.83 1.72
CapEx Per Share
 0.11 0.06 0.08 0.12 0.04
Free Cash Flow to Operating Cash Flow
 0.98 0.99 0.98 0.96 0.98
Dividend Paid and CapEx Coverage Ratio
 66.17 93.48 44.79 25.41 49.92
Capital Expenditure Coverage Ratio
 66.17 93.48 44.79 25.41 49.92
Operating Cash Flow Coverage Ratio
 0.38 0.30 0.32 0.26 0.16
Operating Cash Flow to Sales Ratio
 0.49 0.47 0.47 0.47 0.36
Free Cash Flow Yield
6.16%7.99%7.72%7.66%3.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 31.53 25.49 13.66 17.32 38.52
Price-to-Sales (P/S) Ratio
 7.91 5.77 5.97 5.88 11.80
Price-to-Book (P/B) Ratio
 90.68 165.22 16.67 58.18 45.86
Price-to-Free Cash Flow (P/FCF) Ratio
 16.33 12.51 12.95 13.06 33.09
Price-to-Operating Cash Flow Ratio
 15.90 12.38 12.66 12.55 32.43
Price-to-Earnings Growth (PEG) Ratio
 -1.47 -1.04 0.21 0.39 -0.80
Enterprise Value Multiple
 21.09 17.58 11.35 13.84 28.71
Enterprise Value
 15.08B 10.07B 7.45B 6.26B 9.06B
EV to EBITDA
 20.99 17.58 11.35 13.84 28.71
EV to Sales
 9.06 7.21 7.34 7.55 13.72
EV to Free Cash Flow
 18.71 15.63 15.91 16.76 38.50
EV to Operating Cash Flow
 18.42 15.46 15.56 16.10 37.73
Tangible Book Value Per Share
 -11.60 -12.63 -3.59 -6.11 -5.74
Shareholders’ Equity Per Share
 1.22 0.41 2.87 0.64 1.24
Tax and Other Ratios
Effective Tax Rate
 0.29 0.32 0.20 0.19 0.19
Revenue Per Share
 14.19 11.65 8.01 6.29 4.82
Net Income Per Share
 3.53 2.64 3.50 2.13 1.48
Tax Burden
 0.71 0.68 0.80 0.81 0.81
Interest Burden
 0.97 0.96 0.97 0.95 0.94
Research & Development to Revenue
 0.06 0.06 0.08 0.09 0.10
SG&A to Revenue
 0.14 0.15 0.15 0.00 0.00
Stock-Based Compensation to Revenue
 0.04 0.04 0.04 0.04 0.04
Income Quality
 1.98 2.06 1.08 1.38 1.19
Currency in USD